FDA Clears 21 NMEs In 2003; Average Approval Time Is 16.6 Months
Executive Summary
FDA finished 2003 with slightly more new molecular entity approvals at a slightly faster pace than its 2002 performance
You may also be interested in...
Drug Approvals Will Be Down “Significantly” In ’05, FDA’s Gottlieb Predicts
The number of new molecular entities approved by FDA in 2005 will be significantly fewer than in recent years, Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb predicted
Drug Approvals Will Be Down “Significantly” In ’05, FDA’s Gottlieb Predicts
The number of new molecular entities approved by FDA in 2005 will be significantly fewer than in recent years, Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb predicted
FDA New Molecular Entity Approvals Rebound In 2004; Lyrica Is Fitting Finale
FDA's new molecular entity drug approval tally for 2004 represents a five-year high for the agency